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This randomized clinical noninferiority trial compares solar-powered oxygen delivery vs standard oxygen
delivery using compressed oxygen cylinders among children younger than 13 years with hypoxemic illness
at 2 resource-constrained hospitals in Uganda.
Oxygen is an essential medicine for life-threatening hypoxemic illnesses, including pneumonia, which is
currently the leading cause of childhood mortality worldwide.  However, oxygen is not available in many
pediatric wards in low-income countries. In a survey of 12 African countries, only 44% of 231 health
centers, district hospitals, and provincial or general hospitals had access to oxygen on a continuous basis.
Pragmatic solutions are needed to improve access to oxygen in low-resource settings.
In resource-constrained settings, compressed oxygen cylinders and oxygen concentrators are commonly
used. Oxygen cylinders are ready to use and do not require any electricity; however, their availability may
be compromised by weak stock management, the need for transportation from supplier to hospital, and
leakage from ill-fitting regulators. Oxygen concentrators generate oxygen on site from ambient air through
selective adsorption of nitrogen using aluminum silicate sieve beds. Concentrators overcome the logistical
supply barriers of cylinder oxygen, require minimal service and maintenance, and are more user-friendly
than cylinders. However, oxygen concentrators require a continuous and reliable source of electricity. A
systematic review found that only 34% of hospitals in sub-Saharan Africa have reliable access to
electricity.  Interruptions in oxygen therapy owing to power outages are therefore frequent and potentially
fatal in the settings in which most deaths from pneumonia occur.
Methods
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using solar energy.  We conducted a randomized, placebo-controlled clinical trial of solar-powered oxygen
delivery vs standard oxygen delivery using compressed oxygen cylinders among children younger than 13
years with hypoxemic illness at 2 resource-constrained hospitals in Uganda. The trial protocol and methods
have previously been published  (trial protocol in the Supplement) and the trial was registered
(clinicaltrials.gov NCT02100865). The trial was designed to demonstrate noninferiority of solar-powered
oxygen delivery relative to oxygen cylinders, using a clinically meaningful end point, length of hospital
stay, expressed as a continuous variable using the date and hour of admission and discharge, using a
noninferiority margin of 1 day. The study was reviewed and approved by the Makerere University School of
Biomedical Sciences Research Ethics Committee (REC Protocol SBS 139), the Uganda National Council on
Science and Technology (Ref SS 3331), and the University Health Network Research Ethics Committee,
Toronto, Canada (UHN REB No. 13-6168-AE). Parents of all patients provided written informed consent
for participation in the study.
Results
A total of 130 children (59 girls [45.4%] and 71 boys [54.6%]; mean [SD] age, 16 [22] months) were
enrolled between March 29, 2014, and May 13, 2015; of these, 65 (50.0%) were assigned to solar-powered
oxygen delivery and 65 to cylinder oxygen. Baseline characteristics were similar between groups (Table).
The median length of hospital stay was 4.1 days (interquartile range, 2.9-5.6 days) in the solar-powered
oxygen delivery group and 4.5 days (interquartile range, 3.3-6.9 days) in the cylinder oxygen group; the
difference of medians was –0.41 days (95% CI, –1.2 to 0.43), meeting the prespecified criterion for
noninferiority. In-hospital mortality was similar between groups: 11 patients (17%) in the solar-powered
oxygen delivery group vs 8 patients (12%) in the cylinder oxygen group (risk difference, 4.6%; 95% CI, –
7.8% to 17%). In a competing risk analysis with in-hospital mortality and hospital discharge as competing
events, the time to discharge and mortality were not statistically different between groups (Figure, A). The
increase in peripheral blood oxygen saturation (Figure, B), and the time to wean off oxygen were similar (
Figure, C). Adverse events were similar in both groups.
Five episodes of battery depletion involving 7 patients required recharging the batteries of the solar-powered
oxygen system using the hydroelectric grid or switching patients to the backup oxygen supply. Conversely,
4 patients randomized to receive cylinder oxygen were switched to the backup oxygen supply when
cylinders stocks were depleted, despite our best efforts to maintain adequate stocks of cylinders.
Discussion
Solar-powered oxygen delivery is noninferior to standard oxygen delivery using cylinders among African
children hospitalized with hypoxemic illness. This technological innovation may be suitable for low-
resource hospitals with pediatric inpatient services where the supply chain of cylinders and electrical power
are not reliable. Solar-powered oxygen delivery addresses a critical gap in access to oxygen and has the
potential for global consequences, given the magnitude of childhood pneumonia deaths, currently estimated
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Figures and Tables
Table.
Baseline Characteristics of the 2 Treatment Groups
Characteristic Children, No. (%)
Solar-Powered Oxygen (n = 65) Cylinder Oxygen (N = 65)
Female sex 27 (42) 32 (49)
Age, median (IQR), mo 10 (3-19) 10 (1-22)
Clinical features at enrollment
Cough 53 (82) 51 (78)
Difficulty breathing 58 (89) 56 (86)
Unable to drink or feed 25 (38) 28 (43)
Results of clinical examination at enrollment
Weight, median (IQR), kg 8.0 (5.0-10) 7.0 (4.3-10)
Underweight 9 (14) 9 (14)
Oxygen saturation, median (IQR), % 83 (72-87) 84 (76-87)
Respiratory rate, median (IQR), min 68 (54-78) 66 (48-80)
a
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Tachypnea 48 (74) 47 (72)
Pulse rate, median (IQR), min 160 (145-176) 158 (146-178)
Tachycardia 33 (51) 34 (52)
Temperature, median (IQR), °C 37.6 (36.6-38.5) 37.3 (36.9-38.3)
Fever 26 (40) 34 (52)
Intercostal retractions 44 (68) 47 (72)
Subcostal retractions 52 (80) 41 (63)
Diagnoses at admission
Severe pneumonia or very severe disease 65 (100) 65 (100)
HIV 1/59 (2) 2/55 (4)
Malaria 5 (8) 4 (6)
Radiographic findings
Alveolar consolidation 12/54 (22) 12/55 (22)
Other infiltrate 25/54 (46) 26/55 (47)
No consolidation, infiltrate or effusion 16/54 (30) 18/55 (33)
Abbreviation: IQR, interquartile range.
Weight for age less than first percentile on World Health Organization growth charts.
Respiratory rate greater than 99th percentile for age.
Pulse rate greater than 99th percentile for age.
Axillary temperature greater than 37.5°C.
All children were tested for malaria using rapid diagnostic test (histidine-rich protein–2 antigen) and/or light
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Mortality, Time to Hospital Discharge, Rapid Resolution of Hypoxemia, and Time to Wean Off Oxygen Among
Trial Participants
A, Mortality and time to hospital discharge among trial participants. Mortality (orange lines) and hospital discharge (blue
lines) in the solar-powered oxygen delivery group (solid lines) and cylinder oxygen comparator group (dashed lines) are
modeled as competing risks. Differences between treatment arms were not statistically significantly different for mortality
or time to hospital discharge. B, Rapid resolution of hypoxemia among trial participants. Immediate improvements in
oxygen saturation were observed in both trial arms after administration of oxygen therapy, with no difference between
patients receiving solar-powered oxygen (median change, 15% [interquartile range, 12%-21%]) and cylinder oxygen
(median change, 15% [interquartile range, 11%-23%]). C, Time to wean off oxygen among trial participants. The median
duration of oxygen therapy was similar in patients receiving solar-powered oxygen (2.6 days [interquartile range, 1.6-4.0
days]) and cylinder oxygen (2.1 days [interquartile range, 1.7-4.9 days]). A standardized protocol for stopping oxygen
therapy was observed.
